Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Tofacitinib Citrate in Dermatitis, Atopic: NCT06923228 Clinical Landscape Report 2026
16 October 2026
NCT06923228 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Circularly Permuted TRAIL in Multiple Myeloma: NCT06924424 Clinical Landscape Report 2026
16 October 2026
NCT06924424 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lebrikizumab in Dermatitis, Atopic: NCT06921759 Clinical Landscape Report 2026
16 October 2026
NCT06921759 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GB-7624 in Dermatitis, Atopic: NCT06920693 Clinical Landscape Report 2026
16 October 2026
NCT06920693 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cyclophosphamide in Acute Myeloid Leukemia: NCT06926595 Clinical Landscape Report 2026
16 October 2026
NCT06926595 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fludarabine Phosphate in Myeloid Tumor: NCT06928662 Clinical Landscape Report 2026
16 October 2026
NCT06928662 clinical landscape for Myeloid Tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HS-10374 in Plaque psoriasis: NCT06926582 Clinical Landscape Report 2026
16 October 2026
NCT06926582 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT06928376 Clinical Landscape Report 2026
16 October 2026
NCT06928376 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Onabotulinumtoxin A in Dermatitis, Atopic: NCT06928246 Clinical Landscape Report 2026
16 October 2026
NCT06928246 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ziftomenib in Acute myeloid leukaemia with 11q23 abnormality: NCT06930352 Clinical Landscape Report 2026
16 October 2026
NCT06930352 clinical landscape for Acute myeloid leukaemia with 11q23 abnormality: endpoints, sponsor, phase, geography, readouts, asset context and developm…
9 min read
Lenalidomide in Multiple Myeloma: NCT06932562 Clinical Landscape Report 2026
16 October 2026
NCT06932562 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Itareparib in Recurrent ovarian cancer: NCT06930755 Clinical Landscape Report 2026
16 October 2026
NCT06930755 clinical landscape for Recurrent ovarian cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.